Preferential inactivation of the C5 convertase of the alternative complement pathway by factor I and membrane cofactor protein (MCP)

This publication has 44 references indexed in Scilit:

• Proteolytic elimination of decay-accelerating factor (DAF): Lytic abnormality coincides with removal of DAF in papain-treated human erythrocytes
  Molecular Immunology, 1990
• Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
  The Journal of Experimental Medicine, 1988
• Separation of self from non-self in the complement system
  Immunology Today, 1987
• Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
  The Journal of Experimental Medicine, 1987
• Fast and efficient method for detection and estimation of proteins
  Biochemical and Biophysical Research Communications, 1985
• Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.
  The Journal of Experimental Medicine, 1985
• Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.
  The Journal of Experimental Medicine, 1984
• Mechanism of action of the C3b inactivator: Requiremen for a high molecular weight cofactor (C3b-C4bINA cofactor) and production of a new C3b derivative (C3b′)
  Immunochemistry, 1977
• Third component of human complement: purification from plasma and physicochemical characterization
  Biochemistry, 1976
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
  Nature, 1970